Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 2012. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on August 9, 2012, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, the following acquisitions occurred at a price of 1,496.28 pence per Ordinary Share:
- Acquisition of 2 Ordinary Shares under the personal contribution element of the Plan.
- Acquisition of 2 Ordinary Shares under the matching element of the Plan (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the director's share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the share price of 1,496.28 pence per Ordinary Share on August 9, 2012.
- Confirm the total number of shares acquired (4 total) by Mr. P C Thomson and Mrs. K Thomson under the ShareReward Plan.
- Review the company's ShareReward Plan terms regarding personal contributions and company matching elements.